NEXUS Registry Tracking Patient-Reported Outcomes After Heart Procedures for Coronary Artery Disease and Atrial Fibrillation

What this Trial Is About

Researchers are evaluating patient-reported outcomes for treatments of coronary artery disease and atrial fibrillation Afib at a center with low operator volume. The study aims to show the benefits of receiving care close to home and to assess symptom relief, function, and quality of life from the patients perspective. This research combines national registry data with patient questionnaires to improve quality of care and track outcomes over time. Participants receive routine procedures such as percutaneous coronary intervention PCI for coronary artery disease and surgical or endocardial ablation for Afib. The study collects data through disease-specific questionnaires like the Seattle Angina Questionnaire SAQ and the Atrial Fibrillation Effect on Quality-of-Life AFEQT Questionnaire, along with the Veterans Rand 12-Item Health Survey VR-12. Data is linked with national registries and monitored for quality assurance. Follow-up assessments occur at six months and annually for up to ten years. Participants complete baseline and follow-up questionnaires assessing symptoms, function, and quality of life. Researchers analyze changes in questionnaire scores and monitor hospital readmissions within 90 days after intervention. Safety and complications such as bleeding or vascular injury are recorded. The study involves continuous data validation, training, and statistical analysis to support quality improvement and value-based care over a long-term period.

Cardiovascular Innovation & Research Institute 's NEXUS Registry, the Whole is Greater Than the Parts.